Your session is about to expire
← Back to Search
Diagnostic Test
AdhesioRT for Infertility (AdhesioRT Trial)
N/A
Waitlist Available
Led By Isaac-Jacques Kadoch, MD
Research Sponsored by Clinique Ovo
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Women between the ages of 18 to 40 inclusive at the time of oocyte retrieval
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 14 days after embryo transfer
Awards & highlights
AdhesioRT Trial Summary
This trial is testing a new way to help an embryo implant in the uterus, which may help improve the success rate of pregnancy for people undergoing assisted reproductive techniques.
Who is the study for?
This trial is for women aged 18-40 who are undergoing fertility treatments and have at least two high-quality frozen embryos ready for transfer. They must not be preserving fertility for future use, have severe endometriosis or uterine abnormalities, nor test positive for HIV, Hepatitis B (unless from vaccination), or Hepatitis C.Check my eligibility
What is being tested?
The study tests AdhesioRT to personalize the window of implantation during a single frozen embryo transfer in an attempt to improve pregnancy establishment rates by enhancing uterine receptivity.See study design
What are the potential side effects?
Potential side effects are not explicitly listed but may include typical risks associated with embryo transfers such as infection, bleeding, or complications related to hormonal treatments used in the process.
AdhesioRT Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I am a woman aged 18 to 40.
AdhesioRT Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 14 days after embryo transfer
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~14 days after embryo transfer
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Determination of appropriate window of implantation
Secondary outcome measures
Rate of clinical pregnancy
AdhesioRT Trial Design
2Treatment groups
Active Control
Group I: Study Group - AdhesioRTActive Control1 Intervention
Prior to frozen embryo transfer, participants will proceed with the AdhesioRT test. Participants randomized in the study group will proceed with frozen embryo transfer cycle according window of implantation determined by AdhesioRT.
Group II: Control Group - Standard of CareActive Control1 Intervention
Prior to frozen embryo transfer, participants will proceed with the AdhesioRT test. Participants randomized in the control group will proceed with the first frozen embryo transfer cycle as per standard of care. In the event of unsuccessful implantation (negative serum pregnancy test), participants will proceed with subsequent frozen embryo transfer cycle according to window of implantation determined by AdhesioRT.
Find a Location
Who is running the clinical trial?
Ferring PharmaceuticalsIndustry Sponsor
313 Previous Clinical Trials
440,738 Total Patients Enrolled
60 Trials studying Infertility
32,200 Patients Enrolled for Infertility
Clinique OvoLead Sponsor
31 Previous Clinical Trials
41,387 Total Patients Enrolled
19 Trials studying Infertility
8,207 Patients Enrolled for Infertility
Isaac-Jacques Kadoch, MDPrincipal InvestigatorClinique Ovo
1 Previous Clinical Trials
800 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I am a woman aged 18 to 40.My condition is stage IV severe endometriosis.I have a severe uterine condition or large fibroids (≥ 5 cm) affecting my uterus.I am prescribed a single frozen embryo transfer.
Research Study Groups:
This trial has the following groups:- Group 1: Study Group - AdhesioRT
- Group 2: Control Group - Standard of Care
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does this trial accommodate participants aged 70 and above?
"Interested individuals must meet the age restrictions of this trial, which are 18 at the minimum and 40 at the maximum."
Answered by AI
Who would be the ideal candidates to join this research project?
"The requisites for this clinical trial are to have fertility and be between the ages of 18-40. This particular study aims to recruit 120 patients in total."
Answered by AI
Are there any available slots in this scientific experiment for participants?
"Research hosted on clinicaltrials.gov shows that this medical trial is not presently enrolling patients. Initially published on March 24th 2021, the most recent update was made September 8th 2022. Despite no current recruitment for this particular study, there are 4 other studies in progress seeking participants as of now."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger